BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 12063955)

  • 1. Study of the intrahepatic surgical margin of hilar bile duct carcinoma.
    Okazaki Y; Horimi T; Kotaka M; Morita S; Takasaki M
    Hepatogastroenterology; 2002; 49(45):625-7. PubMed ID: 12063955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Procedure of extended hilar bile duct resection and its application for hilar cholangiocarcinoma.
    Shimada H; Endo I; Fujii Y; Kunihiro O; Tanaka K; Misuta K; Togo S
    Hepatogastroenterology; 2002; 49(44):300-5. PubMed ID: 11995438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical value of additional resection of a margin-positive proximal bile duct in hilar cholangiocarcinoma.
    Shingu Y; Ebata T; Nishio H; Igami T; Shimoyama Y; Nagino M
    Surgery; 2010 Jan; 147(1):49-56. PubMed ID: 19767048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histologic bile duct invasion by a mass-forming intrahepatic cholangiocarcinoma.
    Hirohashi K; Uenishi T; Kubo S; Yamamoto T; Tanaka H; Shuto T; Yamasaki O; Horii K; Kinoshita H
    J Hepatobiliary Pancreat Surg; 2002; 9(2):233-6. PubMed ID: 12140612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical management of hilar bile duct cancer. Preoperative diagnosis, selection of treatment options and clinical outcome.
    Hirai I; Kimura W; Fuse A; Suto K; Sakurai F; Ishiyama S
    Hepatogastroenterology; 2003; 50(51):629-35. PubMed ID: 12828048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of intraoperative bile duct margin assessment for hilar cholangiocarcinoma.
    Endo I; House MG; Klimstra DS; Gönen M; D'Angelica M; Dematteo RP; Fong Y; Blumgart LH; Jarnagin WR
    Ann Surg Oncol; 2008 Aug; 15(8):2104-12. PubMed ID: 18543039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical approach to bismuth Type I and II hilar cholangiocarcinomas: audit of 54 consecutive cases.
    Ikeyama T; Nagino M; Oda K; Ebata T; Nishio H; Nimura Y
    Ann Surg; 2007 Dec; 246(6):1052-7. PubMed ID: 18043110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of hepatectomy in the treatment of hilar bile duct carcinoma.
    Tsuchikawa T; Kondo S; Hirano S; Tanaka E; Anbo Y; Morikawa T; Okushiba S; Katoh H
    Surg Today; 2004; 34(5):405-8. PubMed ID: 15108077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of hepatic resection margin on recurrence and survival in intrahepatic cholangiocarcinoma.
    Tamandl D; Herberger B; Gruenberger B; Puhalla H; Klinger M; Gruenberger T
    Ann Surg Oncol; 2008 Oct; 15(10):2787-94. PubMed ID: 18685896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors of surgical resection in middle and distal bile duct cancer: an analysis of 55 patients concerning the significance of ductal and radial margins.
    Sakamoto Y; Kosuge T; Shimada K; Sano T; Ojima H; Yamamoto J; Yamasaki S; Takayama T; Makuuchi M
    Surgery; 2005 Apr; 137(4):396-402. PubMed ID: 15800484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Our experiences in surgical treatment for hilar cholangiocarcinoma.
    Maeno H; Ono T; Yamanoi A; Nagasue N
    Hepatogastroenterology; 2007; 54(75):669-73. PubMed ID: 17591038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is intraoperative frozen section analysis of the proximal bile ducts in hilar cholangiocarcinoma of limited value?
    Ma WJ; Shrestha A; Li FY
    Cancer Med; 2016 Oct; 5(10):2848-2849. PubMed ID: 27686472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Surgical margin status in hepatectomy for liver tumors].
    Salloum C; Castaing D
    Bull Cancer; 2008 Dec; 95(12):1183-91. PubMed ID: 19091652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aggressive surgical resection for hilar-invasive and peripheral intrahepatic cholangiocarcinoma.
    Nakagohri T; Asano T; Kinoshita H; Kenmochi T; Urashima T; Miura F; Ochiai T
    World J Surg; 2003 Mar; 27(3):289-93. PubMed ID: 12607053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prognostic factors and long term outcome after surgery for hilar cholangiocarcinoma. Univariate and multivariate analysis].
    Ramacciato G; Di Benedetto F; Cautero N; Masetti M; Mercantini P; Corigliano N; Nigri G; Lauro A; Ercolani G; Del Gaudio M; De Ruvo N; Pinna AD
    Chir Ital; 2004; 56(6):749-59. PubMed ID: 15771027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hilar bile duct cancer associated with preoperatively undetectable von Meyenburg complex--report of a case.
    Eguchi S; Tajima Y; Yanaga K; Okudaira S; Furui J; Hayashi T; Kanematsu T
    Hepatogastroenterology; 2004; 51(59):1301-3. PubMed ID: 15362738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changing trends in surgical outcomes after major hepatobiliary resection for hilar cholangiocarcinoma: a single-center experience over 25 years.
    Sano T; Shimada K; Sakamoto Y; Esaki M; Kosuge T
    J Hepatobiliary Pancreat Surg; 2007; 14(5):455-62. PubMed ID: 17909713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical impact of the surgical margin status in hepatectomy for solitary mass-forming type intrahepatic cholangiocarcinoma without lymph node metastases.
    Shimada K; Sano T; Sakamoto Y; Esaki M; Kosuge T; Ojima H
    J Surg Oncol; 2007 Aug; 96(2):160-5. PubMed ID: 17443744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathologic features in patients with long-term survival following resection for intrahepatic cholangiocarcinoma.
    Uenishi T; Hirohashi K; Kubo S; Yamamoto T; Yamazaki O; Shuto T; Tanaka H; Kinoshita H
    Hepatogastroenterology; 2003; 50(52):1069-72. PubMed ID: 12845984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoadjuvant photodynamic therapy as a new approach to treating hilar cholangiocarcinoma: a phase II pilot study.
    Wiedmann M; Caca K; Berr F; Schiefke I; Tannapfel A; Wittekind C; Mössner J; Hauss J; Witzigmann H
    Cancer; 2003 Jun; 97(11):2783-90. PubMed ID: 12767091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.